SERVICES

Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Case Study: High-Dose Intravenous Vitamin C in the Treatment of a Patient with Adenocarcinoma of the Kidney

A 70-year old white male was seen and treated
previously at this center for “headaches”. In late
1985 he complained of pain in his right side. A
urinalysis showed gross hematuria. He was
referred to a urologist who, through x-rays and
CT. scans, diagnosed the patient as having a
small stone in the right kidney, and a large, solid,
space occupying mass in the lower pole of the
right kidney. Adenocarcinoma was suspected and
in December 1985, a radical nephrectomy was
performed on the right kidney and
adenocarcinoma was confirmed by pathological
studies. His left kidney was completely
functional.
He was followed by an oncologist at another
clinic. About three months after surgery, the
patient’s x-rays and CT. scan studies showed
“multiple pulmonary lesions and lesions in
several areas of his liver which were abnormal
and periaortic lymphadenopathy”. None of the
lesions were biopsied.
The patient decided not to undergo
chemotherapy, hormone therapy or cytotoxic
treatment of any kind. He requested and was
started on vitamin C intravenous treatment. He
was started on 30 grams of vitamin C (Ascorbic
Acid Injection, Sodium Ascorbate equivalent to
250 mg/mL, Steris Laboratories, Inc. Phoenix,
Arizona 85043) in 250 mL of Ringer’s Lactate
given by intravenous injection (60 drops per
minute) twice a week.
In April 1986, about six weeks after the x-ray
and CT. scan studies, the oncologist’s report showed “the patient returns feeling well.
His exam is totally normal. His chest x-ray shows
a dramatic improvement in pulmonary nodules
compared to six weeks ago. The periaortic
lymphadenopathy is completely resolved. …
either he has had a viral infection with pulmonary
lesions with lymphadenopathy that has resolved
or (two) he really did have recurrent kidney
cancer which is responding to your vitamin C
therapy.”
In June 1986, the oncologist reported the
patient “has been receiving vitamin C shots now
twice weekly, feeling well and playing golf. On
exam day, his weight is up a couple of pounds
and he looks well. He has absolutely no evidence
of progres-sivecancer.”… “I recommend you
continue your vitamin C shots until he returns in
six weeks time for a repeat chest x-ray and CT.
scan of his abdomen.”
The oncologist’s report in July 1986 stated “the
patient has been feeling well with no symptoms
of cancer … there is no evidence of progressive
cancer. He looks well… chest x-ray today is
totally normal. The pulmonary nodules are
completely gone. There is no evidence of lung
metastasis, liver metastasis or lymph node metastasis
today, whatsoever.”
The report of September 1986 stated “… over
all, the patient is totally well, golfing and having
no symptoms from his cancer. On exam today,
there is absolutely no evidence of recurrent
cancer and we have opted to continue our
observation. I suggest he continue with you the
vitamin C shots …”
In March 1987,15 months after surgery, the
report stated “… is feeling well, and on exam
today there is absolutely no evidence of recurrent
cancer. We thus thought (this patient) has no
evidence of recurrent cancer and opt to continue his follow-up. The patient
wishes to continue his vitamin C shot once weekly
as well, which seems reasonable to me.”
To date, after 3’/2 years the patient remains
cancer free. He will continue to be followed both
at our center and by the oncologist. The patient’s
vitamin C treatment protocol was 30 grams of
vitamin C in 250 mL of Ringer’s Lactate given by
intravenous injection (60 drops per minute) twice a
week for seven months. The treatments were then
reduced to one per week and 1 mL of magnesium
was added to the vitamin C and Ringer’s Lactate.
This treatment lasted for eight months, then for six
months he received 15 grams of vitamin C weekly
in 250 mL of Ringer’s Lactate with 1.0 mL of
magnesium. Today, he returns at irregular intervals
for a 30 gram vitamin C intravenous treatment.
During and after the treatments, the patient
showed no toxic, or unusual side effects from the
high-dosage I.V. vitamin C therapy. Periodic blood
chemistry profiles and urine studies were normal.

Published on 11-30-2012